Evidence map›Paper›PMID 29114958›Full record

ArticleProtein science : a publication of the Protein Society2018

Evidence for multiple modes of neutrophil serine protease recognition by the EAP family of Staphylococcal innate immune evasion proteins.

Daphne A C Stapels, Jordan L Woehl, Fin J Milder, Angelino T Tromp, Aernoud A van Batenburg, Wilco C de Graaf, Samuel C Broll, Natalie M White, Suzan H M Rooijakkers, Brian V Geisbrecht

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Arteriosclerosis, thrombosis, and vascular biology · 2022
    Review
  6. Local structural plasticity of theThe Journal of biological chemistry · 2020
    Article
  7. Article
  8. Article
  9. Immune Evasion byMicrobiology spectrum · 2019
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Daphne A C StapelsDepartment of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Jordan L WoehlDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
Fin J MilderDepartment of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Angelino T TrompDepartment of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Aernoud A van BatenburgDepartment of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Wilco C de GraafDepartment of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Samuel C BrollDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
Natalie M WhiteDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
Suzan H M RooijakkersDepartment of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Brian V GeisbrechtDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
University Medical Center Utrecht · NLKansas State University · US

Funding

Structure Function Analysis of Staphylococcal Complement InhibitorsR01AI071028 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI GEISBRECHT, BRIAN V · 2008 to 2012
$1.5M
Novel Staphylococcal Inhibitors of Neutrophil Granule EnzymesR01GM121511 · NIGMS · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2017 to 2020
$1.2M
Inhibition of the Classical & Lectin Complement Pathways by Staphylococcus aureus EapR21AI111203 · NIAID · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2015 to 2016
$375k
European Research Council 639209NIAID NIH HHS R01 AI071028NIAID NIH HHS R21 AI111203NIGMS NIH HHS R01 GM121511
6 · The paper itself

Abstract

Neutrophils contain high levels of chymotrypsin-like serine proteases (NSPs) within their azurophilic granules that have a multitude of functions within the immune system. In response, the pathogen Staphylococcus aureus has evolved three potent inhibitors (Eap, EapH1, and EapH2) that protect the bacterium as well as several of its secreted virulence factors from the degradative action of NSPs. We previously showed that these so-called EAP domain proteins represent a novel class of NSP inhibitors characterized by a non-covalent inhibitory mechanism and a distinct target specificity profile. Based upon high levels of structural homology amongst the EAP proteins and the NSPs, as well as supporting biochemical data, we predicted that the inhibited complex would be similar for all EAP/NSP pairs. However, we present here evidence that EapH1 and EapH2 bind the canonical NSP, Neutrophil Elastase (NE), in distinct orientations. We discovered that alteration of EapH1 residues at the EapH1/NE interface caused a dramatic loss of affinity and inhibition of NE, while mutation of equivalent positions in EapH2 had no effect on NE binding or inhibition. Surprisingly, mutation of residues in an altogether different region of EapH2 severely impacted both the NE binding and inhibitory properties of EapH2. Even though EapH1 and EapH2 bind and inhibit NE and a second NSP, Cathepsin G, equally well, neither of these proteins interacts with the structurally related, but non-proteolytic granule protein, azurocidin. These studies expand our understanding of EAP/NSP interactions and suggest that members of this immune evasion protein family are capable of diverse target recognition modes.

Indexed as

Bacterial ProteinsBinding SitesCell LineHumansImmune EvasionLeukocyte ElastaseModels, MolecularMutationProtein BindingProtein DomainsSerine Proteinase InhibitorsStaphylococcus aureusBacterial ProteinsELANE protein, humanLeukocyte ElastaseSerine Proteinase Inhibitorsneutrophil elastaseneutrophil serine proteasesprotease inhibitorprotein interactionsS. aureus

Identifiers

PMID29114958
PMCPMC5775164
OpenAlexW2767385440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.